Other Cancers 2-Year Follow-up on Real-Life Standards of Care in Relapsed/Refractory Multiple Myeloma Sep 06, 2023
Other Cancers Final Efficacy & Safety of Melflufen Combo in Relapsed/Refractory Multiple Myeloma Sep 06, 2023
Other Cancers Analyzing Pelabresib (CPI-0610) + Ruxolitinib for Treatment-Naïve Myelofibrosis Patients Sep 05, 2023
Other Cancers Disease Progression and Leukemic Transformation in Lower-Risk Myelofibrosis Patients Sep 05, 2023
Other Cancers Elotuzumab, an Anti-SLAMF7 Monoclonal Antibody in Patients with Myelofibrosis Sep 05, 2023
